Celltrion
068270.KS
#756
Rank
S$42.13 B
Marketcap
S$184.78
Share price
1.22%
Change (1 day)
15.01%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Half-year Reports

Thumbnail Celltrion
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2020-h1

Half-year Report 2020-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2019-h1

Half-year Report 2019-h1

Language: English

View Half-year Report